ABTI
vs
S&P 500
ABTI
S&P 500
Over the past 12 months, ABTI has significantly outperformed S&P 500, delivering a return of +42% compared to the S&P 500's +15% growth.
Stocks Performance
ABTI vs S&P 500
Performance Gap
ABTI vs S&P 500
Performance By Year
ABTI vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Alterola Biotech Inc
Glance View
Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.